These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 176830)

  • 1. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigations of the urinary cAMP-excretion in pseudohypoparathyroidism (author's transl)].
    Stögmann W
    Padiatr Padol Suppl; 1977; (5):63-9. PubMed ID: 199875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudohypoparathyroidism. Disease of the second messenger].
    Stögmann W
    Fortschr Med; 1976 Oct; 94(29):1638-40. PubMed ID: 186374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of pseudohypoparathyroidism in adolescent boys.
    Kabícek P; Kutílek S; Bayer M; Stĕpán JJ
    Acta Univ Carol Med (Praha); 1994; 40(1-4):53-6. PubMed ID: 9355673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary excretion of cAMP after PTH injection in patients with hypohyperparathyroidism (author's transl)].
    González Macías J; Gertner JM; Brenton DB
    Med Clin (Barc); 1979 Oct; 73(6):219-21. PubMed ID: 232737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoparathyroidism type IA and II with severe neuropsychic manifestations.
    Kutílek S; Kabícek P; Nedvídková J; Bayer M
    Turk J Pediatr; 2001; 43(1):70-5. PubMed ID: 11297164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism.
    Bell NH; Avery S; Sinha T; Clark CM; Allen DO; Johnston C
    J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple pre- and postreceptor defects in pseudohypoparathyroidism (a multicenter study with twenty four patients).
    Radeke HH; Auf'mkolk B; Jüppner H; Krohn HP; Keck E; Hesch RD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):393-402. PubMed ID: 3001127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium administration on renal responsiveness to parathyroid hormone in pseudohypoparathyroidism type I and II -- in comparison with normals, idiopathic and surgical hypoparathyroidism.
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Endocrinol Jpn; 1979 Apr; 26(2):147-57. PubMed ID: 225161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects].
    Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K
    Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
    Connors MH; Irias JJ; Golabi M
    Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical heterogeneity of pseudohypoparathyroidism: from hyper- to hypocalcemia.
    Shalitin S; Davidovits M; Lazar L; Weintrob N
    Horm Res; 2008; 70(3):137-44. PubMed ID: 18663313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
    Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
    Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.